Seasoned investor and operational executive focused on healthcare and growth-stage technology companies, Margaret Nickens brings public markets and private equity sensibilities to board and portfolio roles. She has led cross-functional teams, structured transactions and overseen M&A and capital-raising initiatives at mid-market firms. Known for strategic diligence, commercial scaling and governance expertise, she advises CEOs and investors on go-to-market, partnerships and exit planning.
Seasoned investor and operational executive focused on healthcare and growth-stage technology companies, Margaret Nickens brings public markets and private equity sensibilities to board and portfolio roles. She has led cross-functional teams, structured transactions and overseen M&A and capital-raising initiatives at mid-market firms. Known for strategic diligence, commercial scaling and governance expertise, she advises CEOs and investors on go-to-market, partnerships and exit planning.
Combines public-market rigor with private-equity playbooks to back growth-stage healthcare and technology companies where commercial strategy and governance drive value. Prioritizes diligence on product-market fit, revenue model scalability and partnership-led distribution; structures deals that align management incentives with clear milestones and exit optionality. Employs a pragmatic time horizon focused on accelerated commercial scaling and de-risking via staged capital, active board engagement, and disciplined M&A or capital-raise pathways to crystallize returns.
Combines public-market rigor with private-equity playbooks to back growth-stage healthcare and technology companies where commercial strategy and governance drive value. Prioritizes diligence on product-market fit, revenue model scalability and partnership-led distribution; structures deals that align management incentives with clear milestones and exit optionality. Employs a pragmatic time horizon focused on accelerated commercial scaling and de-risking via staged capital, active board engagement, and disciplined M&A or capital-raise pathways to crystallize returns.
| Trades 907 | Longs Won 577/907 63% | Profit Factor 5.32 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $186,580.88 |
| Average Win $59,005.67 | Best Trade (Oct 14) $3.4M | Sharpe Ratio -172.69 |
| Average Loss -$19,377.51 | Worst Trade (Oct 14) -$268,076.02 | Z-Score -1.68 (91.71%) |
| Commissions $0 | Avg. Trade Length 10m 1w 3d | Expectancy $30,672.66 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 7,634 | 6,870 | 6,107 | 5,344 | 4,580 | 3,817 | 3,053 | 2,290 | 1,527 | 763 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 12,292 | $3.08M | $4.24M | - | $1.16M | 37.8% | +0.901% |
ABBV AbbVie Inc. | 1,717 | $449,150 | $489,207.64 | - | $40,057.64 | 8.92% | +0.536% |
AIPO Defiance AI & Power Infrastructure ETF | 13,466 | $449,898.91 | $354,357.79 | - | -$95,541.12 | -21.24% | -0.922% |
AMAT Applied Materials, Inc. | 465 | $336,481.98 | $196,634.55 | - | -$139,847.43 | -41.56% | -1.66% |
AMD Advanced Micro Devices, Inc. | 338 | $196,347.43 | $184,345.2 | - | -$12,002.23 | -6.11% | -2.993% |
AMGN Amgen Inc. | 1,259 | $530,714 | $549,251.34 | - | $18,537.34 | 3.49% | +0.514% |
AMZN Amazon.com Inc | 36,758 | $7.51M | $9.32M | - | $1.81M | 24.03% | -0.471% |
ANET Arista Networks, Inc. | 3,494 | $465,420.65 | $638,179.1 | - | $172,758.45 | 37.12% | -1.579% |
APH Amphenol Corporation | 6,333 | $279,158.64 | $513,606.3 | - | $234,447.66 | 83.98% | -0.479% |
ARKX ARK Space & Defense Innovation ETF | 10,178 | $345,153.48 | $310,174.55 | - | -$34,978.93 | -10.13% | -0.18% |
AVGO Broadcom Inc. | 15,673 | $3.65M | $5.3M | - | $1.65M | 45.22% | -1.849% |
BKSE BNY Mellon US Small Cap Core Equity ETF | 5,412 | $203,015.39 | $227,168.7 | - | $24,153.31 | 11.9% | +0.465% |
BLK BlackRock, Inc. | 930 | $984,276 | $1.06M | - | $77,114.4 | 7.83% | +1.829% |
BNY BlackRock New York Municipal Income Trust | 2,725 | $394,117 | $391,745.97 | - | -$2,371.03 | -0.6% | +1.175% |
CEG Constellation Energy Corporation | 1,312 | $415,904.84 | $360,012.8 | - | -$55,892.04 | -13.44% | -0.218% |
CGDV Capital Group Dividend Value ETF | 29,398 | $1.11M | $1.45M | - | $344,561.65 | 31.11% | 0.0 |
CLIP Global X 1-3 Month T-Bill ETF | 27,507 | $2.76M | $2.76M | - | -$3,025.5 | -0.11% | +0.03% |
CLOA iShares AAA CLO ETF | 4,649 | $240,703.75 | $241,050.65 | - | $346.9 | 0.14% | +0.039% |
COF Capital One Financial Corporation | 2,614 | $504,696 | $530,498.23 | - | $25,802.23 | 5.11% | +2.054% |
COST Costco Wholesale Corporation | 679 | $622,028.7 | $669,710.33 | - | $47,681.63 | 7.67% | +0.85% |